Trial Number

379-23

Condition

Prostate Cancer

Participant Age Range

50 years and older

Participant Gender

Male

Enrolling Participants

Yes

Overview

“Prospective, Multicenter, Single-Arm Study of Vanquish Water Vapor Ablation for PrOstate CanceR”

The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device in treating patients with Gleason Grade Group 2 localized intermediate-risk prostate cancer.

Provider

Daniel Su, MD

Urology
Laguna Hills, Irvine
+ More
View Profile

Location

Saddleback Medical Center

24451 Health Center Drive
Laguna Hills
949-837-4500
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Saddleback Medical Center
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.